Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Suven Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543064NSE Symbol: SUVENPHARP/E(TTM):125.95
ISIN Demat:INE03QK01018Div & Yield %:0EPS(TTM):9.65
Book Value(Rs):80.7611632Market Cap ( Cr.):30939.82Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 1024.991330.081320.221009.72833.79377.83
Excise Duty0.000.000.000.000.000.00
Net Sales1024.991330.081320.221009.72833.79377.83
Other Income 55.0944.55187.7914.2418.120.60
Stock Adjustments -53.8820.9460.358.3711.0521.32
Total Income1026.201395.571568.361032.33862.96399.75
EXPENDITURE :      
Raw Materials 248.38421.36459.46310.32240.24124.52
Power & Fuel Cost46.1671.3559.5544.2038.2418.06
Employee Cost 126.88108.58100.4876.2365.1029.63
Other Manufacturing Expenses 83.19101.96115.2590.7666.4933.83
Selling and Administration Expenses 38.8543.5752.6244.9344.7216.23
Miscellaneous Expenses 17.7513.5010.928.615.265.34
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure561.21760.33798.29575.05460.05227.60
Operating Profit465.00635.24770.08457.28402.91172.15
Interest 7.4312.758.5311.6621.812.79
Gross Profit457.57622.49761.55445.62381.10169.36
Depreciation48.7943.1039.1031.6423.5111.50
Profit Before Tax408.78579.39722.45413.98357.59157.86
Tax97.37142.45157.63101.7288.8133.17
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax6.594.346.723.62-1.3015.42
Reported Net Profit304.82432.60558.10308.65270.08109.27
Extraordinary Items 32.5310.5514.532.514.730.11
Adjusted Net Profit272.29422.05543.57306.14265.35109.16
Adjst. below Net Profit -0.30-0.26-0.76-0.84-13.90315.80
P & L Balance brought forward1490.071276.39835.88568.52390.980.00
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.00218.65116.8340.4678.6434.09
P & L Balance carried down1794.591490.071276.39835.88568.52390.98
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.00600.00500.00200.00500.000.00
Earnings Per Share-Unit Curr11.9716.9921.9212.1221.2220.60
Earnings Per Share(Adj)-Unit Curr11.9716.9921.9212.1210.61NA
Book Value-Unit Curr80.7668.7259.7441.8461.500.00